NEW YORK, June 19 - Although recent management changes at Nanogen might make it seem the company is struggling to find its footing, the company's new CEO Randy White told GenomeWeb the changes in personnel come with the company's shift in focus from the research to the clinical diagnostics market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.